CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Aug. 31, 2013	Nov. 30, 2012
ASSETS
Cash and cash equivalents	$ 178,121	$ 199,472
Receivable from warrant holder	130,800	0
Other current assets	14,617	11,293
Total current assets	323,538	210,765
Property and equipment, net of accumulated depreciation of $40,561	0	0
Other assets	280	280
Total assets	323,818	211,045
LIABILITIES AND EQUITY (DEFICIENCY)
Accounts payable and accrued expenses	1,085,649	1,106,177
Payable to related party	50,000	50,000
Advance from warrant holder	0	50,000
Convertible debentures	46,596	0
Current portion of deferred revenue	49,318	49,318
Total current liabilities	1,231,563	1,255,495
Non-current liabilities
Convertible debentures	0	56,026
Deferred revenue, net of current portion	461,753	498,741
Derivative liability related to Series B convertible preferred stock	30,587	19,245
Total non-current liabilities	492,340	574,012
Total liabilities	1,723,903	1,829,507
Commitments and contingencies
Equity (Deficiency) MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	0	0
Common stock, $0.01 par value; 3,000,000,000 shares authorized; 2,391,239,613 and 1,349,803,029 shares issued and outstanding at August 31, 2013 and November 30, 2012, respectively	23,912,396	13,498,030
Additional paid-in capital	18,554,395	27,755,595
Accumulated deficit	(43,158,172)	(42,254,594)
Total MultiCell Technologies, Inc. stockholders' equity (deficiency)	(229,546)	(539,134)
Noncontrolling interests	(1,170,539)	(1,079,328)
Total equity (deficiency)	(1,400,085)	(1,618,462)
Total liabilities and equity (deficiency)	323,818	211,045
Series B Convertible Preferred Stock [Member]
Equity (Deficiency) MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	461,835	461,835
Total equity (deficiency)	461,835	461,835
Series I Convertible Preferred Stock [Member]
Equity (Deficiency) MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	0	0
Total equity (deficiency)	$ 0	$ 0